Abstracts Archive - Page 1460 of 2607 - ACR Meeting Abstracts

Abstract Number: 1091 • 2017 ACR/ARHP Annual Meeting
The Utility of Electronic Consultation in the Management of Gout at the Veterans Affairs Medical Center
Juliana Chang¹, Michelle DiFiore¹ and Maida Wong^2,3, ¹Internal Medicine, University of California, Irvine, School of Medicine, Orange, CA, ²Rheumatology, University of California, Irvine, School of Medicine, Orange, CA, ³Rheumatology, Tibor Rubin VA Medical Center in Long Beach, Long Beach, CA
Background/Purpose: Gout is the most common inflammatory arthritis in adults worldwide. It can be managed by primary care physicians (PCPs), but complex cases often require…
Abstract Number: 1092 • 2017 ACR/ARHP Annual Meeting
The Ottawa Biologics Safety and Screening Tool
Chrisanna Dobrowolski¹, Ines Midzic², Denise Boone², Anne McCarthy³, Doug Smith², John Thomson², Sheryl Izzi⁴ and Susan Humphrey-Murto², ¹Internal Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada, ²Division of Rheumatology, Department of Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada, ³Division of Infectious Diseases, Department of Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada, ⁴Division of Endocrinology, Department of Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada
Background/Purpose : A large proportion of patients with rheumatologic diseases are now being treated with biologic therapies. Estimates of the use of biologics in patients…
Abstract Number: 1093 • 2017 ACR/ARHP Annual Meeting
Effectiveness of the Outreach Model for Rheumatology Specialty Clinics to On-Reserve First Nations in Canada: System-Level and Individual Measures of Performance and Outcomes
Sujay Nagaraj¹, Claire Barber², Margaret Kargard³, Tyler White³ and Cheryl Barnabe⁴, ¹McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, AB, Canada, ²Medicine, University of Calgary, Calgary, AB, Canada, ³Siksika Health Services, Siksika, AB, Canada, ⁴Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
Background/Purpose: Inflammatory arthritis (IA) disproportionately affects Canada’s First Nations population. A Model of Care (MoC) consisting of rheumatology specialty services embedded in the primary care…
Abstract Number: 1094 • 2017 ACR/ARHP Annual Meeting
A Model for Improved Management of Fragility Fractures: Navigating the Fracture Liaison Service
Marcy B. Bolster¹, Smriti Cevallos², Lisa Beyer², Henry M. Kronenberg² and Ben Leder², ¹Massachusetts General Hospital, Boston, MA, ²Endocrine, Massachusetts General Hospital, Boston, MA
Background/Purpose: Fragility fractures are associated with significant morbidity, mortality and healthcare costs, yet most fracture patients are neither evaluated nor treated for their underlying osteoporosis…
Abstract Number: 1095 • 2017 ACR/ARHP Annual Meeting
Increasing Lipid Panel Monitoring in a Rheumatology Clinic
Anju Mohan¹ and Beth Scholz², ¹Internal Medicine-Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, ²Internal Medicine - Rheumatology, University of Texas Health Science Center at Houston, Houston, TX
Background/Purpose: Patients with autoimmune conditions are at increased risk for cardiovascular disease (CVD) compared to the general population. It is not routine practice at UT…
Abstract Number: 1096 • 2017 ACR/ARHP Annual Meeting
Clinical Significance of RNP Antibodies in Diagnosis of Systemic Autoimmune Rheumatic Disease When Detected By Multiplex Immunoassay
Heather Bukiri¹, Amish Dave², Erin Bauer², Vivian Stone², Chris Chong³ and Punam Verma⁴, ¹Graduate Medical Education, Virginia Mason Medical Center, Seattle, WA, ²Rheumatology, Virginia Mason Medical Center, Seattle, WA, ³Virginia Mason Medical Center, Seattle, WA, ⁴Microbiology/Immunology General Lab, Virginia Mason Medical Center, Seattle, WA
Background/Purpose: A large multicenter healthcare system recently adopted multiplex immunoassay as an initial screen for antinuclear antibody (ANA) with confirmatory reflex testing by immunofluorescence antibody…
Abstract Number: 1097 • 2017 ACR/ARHP Annual Meeting
Investigating Opportunities for Cost Conscious Care: A Review of Physician Practice in Ordering Anti-Nuclear Antibody Testing at an Academic Community Hospital
Hrudya Abraham, Jorge Espinal and Sindhu Joseph, Internal Medicine, MacNeal Hospital, Berwyn, IL
Background/Purpose: More than 94,000 ANA tests are performed each year resulting in an estimated cost of 2.24 million dollars annually. The American College of Rheumatology…
Abstract Number: 1098 • 2017 ACR/ARHP Annual Meeting
Glucose-6-Phosphate Dehydrogenase Testing in a US Veterans Healthcare System: Are We Ordering Unnecessary Tests?
Tracy Driver¹, Kevin Hsu², Meika A. Fang³ and Ari Weinreb³, ¹Medicine, Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, CA, ²Cedars-Sinai Medical Center, Los Angeles, CA, ³VA Greater Los Angeles Healthcare System, Los Angeles, CA
Background/Purpose: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked genetic defect that causes a non-immune hemolytic anemia affecting more than 400 million people worldwide. When initiating…
Abstract Number: 1099 • 2017 ACR/ARHP Annual Meeting
Hepatitis B Reactivation in Rheumatologic Patients
Yassir Daghistani¹, Fergus To², Patrick Doyle^3,4, Hin Hin Ko⁵, Mel Krajden^3,4, Jason Kur², Alnoor Ramji⁶, Kam Shojania², Edward Tam⁵, John Wade², Eric Yoshida⁵, Graham Reid², Siegfried Erb⁵ and Mollie Carruthers², ¹Medicine, University of British Columbia, Vancouver, BC, Canada, ²Rheumatology, University of British Columbia, Vancouver, BC, Canada, ³Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada, ⁴BC Centre for Disease Control, Vancouver, BC, Canada, ⁵Gastroenterology, University of British Columbia, Vancouver, BC, Canada, ⁶Gatroenterology, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: The widespread usage of biologic disease modifying anti-rheumatic drugs (bDMARDs) in rheumatology has increased the risk of hepatitis B virus (HBV) re-activation. The prevalence…
Abstract Number: 1100 • 2017 ACR/ARHP Annual Meeting
Communication between Inpatient and Outpatient Specialty Clinicians: Developing a Better Understanding of Patients with Rheumatoid Arthritis Who Are Admitted to the Hospital
Abraham Tacang¹, Christina Downey², Alfred Denio¹, Eric Newman³ and Lisa L. Schroeder⁴, ¹Rheumatology, Geisinger Medical Center, Danville, PA, ²Geisinger Medical Center, Danville, PA, ³Department of Rheumatology, Geisinger Medical Center, Danville, PA, ⁴Rheumatology, Geisinger Health System, Danville, PA
Background/Purpose: Effective communication is essential in caring for medically complex patients with rheumatoid arthritis (RA). Communication between clinicians becomes even more crucial when a patient…
Abstract Number: 1101 • 2017 ACR/ARHP Annual Meeting
Systematic Physician Assessment Beyond Inflammation in Routine Rheumatology Care Using Visual Analog Scale Scores for Inflammation, Damage, and Distress to Document Patient Status and Support Clinical Decisions: Analysis of Inter-Rater Reliability
Shakeel M. Jamal¹, Theodore Pincus², Isabel Castrejón², Jacquelin R. Chua¹, Aman Kugasia¹, Juan Schmukler¹, Stacy Weinberg¹ and Joel A. Block³, ¹Division of Rheumatology, Rush University Medical Center, Chicago, IL, ²Rheumatology, Rush University Medical Center, Chicago, IL, ³Rush University Medical Center, Chicago, IL
Background/Purpose: A physician global estimate of patient status (DOCGL) on a 0-10 visual analog scales (VAS) is as effective as any rheumatoid arthritis (RA) Core…
Abstract Number: 1102 • 2017 ACR/ARHP Annual Meeting
Choosing Unwisely: HLA-B27 Testing and Adherence to Choosing Wisely Practices in a Large Integrated Academic Healthcare System
Marc W. Nolan^1,2, Morgan M. Brown³ and Elie Gertner^1,2, ¹Section of Rheumatology, Regions Hospital, St. Paul, MN, ²Division of Rheumatology, University of Minnesota Medical School, Minneapolis, MN, ³HealthPartners Institute, St. Paul, MN
Background/Purpose: The ACR in 2013 and the Canadian Rheumatology Association (CRA) in 2015 published their respective Choosing Wisely recommendations to promote evidence-based care and reduce…
Abstract Number: 1103 • 2017 ACR/ARHP Annual Meeting
Towards Recommendations on Functional Assessment Status Measures for Rheumatoid Arthritis: Preliminary Results from a Systematic Review
Claire Barber¹, JoAnn Zell², Jinoos Yazdany³, Aileen Davis⁴, Linda S. Ehrlich-Jones⁵, Carter Thorne⁶, Donna Everix⁷, Laura Cappelli⁸ and Kaleb Michaud⁹, ¹Medicine, University of Calgary, Calgary, AB, Canada, ²National Jewish Medical Center, Denver, CO, ³Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, ⁴Health Care and Outcomes Rsrch, Toronto Western Research Institute, University Health Network, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada, ⁵Rehabilitation Institute Chicago, Chicago, IL, ⁶Southlake Regional Health Centre, Newmarket, Newmarket, ON, Canada, ⁷OnMyCare Home Health, Fremont, CA, ⁸Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁹Rheumatology & Immunology, University of Nebraska Medical Center and National Data Bank for Rheumatic Diseases, Omaha, NE
Background/Purpose: Functional status assessment measures (FSAMs) are important outcomes in rheumatology and used to monitor response to treatment and aid in prediction of rheumatic disease…
Abstract Number: 1104 • 2017 ACR/ARHP Annual Meeting
A Genome-Wide Association Study of Gout in People of European Ancestry
Tony R. Merriman¹, Murray Cadzow¹, Marilyn E. Merriman¹, Amanda Phipps-Green¹, Ruth Topless¹, Abhishek Abhishek², Mariano Andrés³, Linda A. Bradbury⁴, Russell Buchanan⁵, Katie Cremin⁶, Erika De Guzman⁶, Janak de Zoysa⁷, Michael Doherty⁸, Catherine Hill⁹, Tom W.J. Huizinga¹⁰, Tim Jansen¹¹, M. Janssen¹², Leo .A.B. Joosten¹³, Fina Kurreeman¹⁴, Susan Lester¹⁵, Frederic Liote¹⁶, Donia Macartney-Coxson¹⁷, Hirotaka Matsuo¹⁸, Geraldine M. McCarthy¹⁹, Sally McCormick²⁰, Rinki Murphy²¹, Karel Pavelka²², Fernando Perez-Ruiz²³, Juan Puig²⁴, Timothy RDJ Radstake²⁵, Philip Riches²⁶, Maureen Rischmueller²⁷, Edward Roddy²⁸, Malcolm Smith²⁹, Eli A. Stahl³⁰, Blanka Stiburkova³¹, Richard Stubbs³², Anne-Kathrin Tausche³³, Rosa Torres³⁴, Rob Walker¹, Ken Yamamoto³⁵, Matthew A. Brown⁶, Hyon K. Choi³⁶, Nicola Dalbeth²¹, Jeffrey N. Miner³⁷, Alexander So³⁸, Lisa K. Stamp³⁹ and Tanya Major⁴⁰, ¹University of Otago, Dunedin, New Zealand, ²Devision of Rheumatology, University of Nottingham, NG5 1PB, England, ³Reumatología, Hospital General Universitario Alicante, Alicante, Spain, ⁴Queensland University of Technology, Brisbane, Australia, ⁵University of Melbourne, Melbourne, Australia, ⁶Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Brisbane, Australia, Brisbane, Australia, ⁷Waitemata District Health Board, Auckland, New Zealand, ⁸Academic Rheumatology, University of Nottingham, Nottingham, Great Britain, ⁹Medicine, The University of Adelaide, Adelaide, Australia, ¹⁰Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ¹¹VieCuri Medical Center, Venlo, Netherlands, ¹²Department of Rheumatology, Rijnstate Hospital Arnhem, Arnhem, Netherlands, ¹³Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands, ¹⁴Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, Leiden, Netherlands, ¹⁵Rheumatology, Queen Elizabeth Hospital, Woodville South, Australia, ¹⁶University Paris Diderot, Paris, France, ¹⁷Institute if Environmental and Scientific Reseacrh, Wellington, New Zealand, ¹⁸Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Japan, ¹⁹Div of Rheumatology, Mater Misericordiae University Hospital, Dublin, Ireland, ²⁰Department of Biochemistry, University of Otago, Dunedin, New Zealand, ²¹University of Auckland, Auckland, New Zealand, ²²Institute of Rheumatology, Prague, Czech Republic, ²³BioCruces Health Research Institute, Barakaldo, Spain, ²⁴Hospital Universitario La Paz, Madrid, Spain, ²⁵Rheumatic Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ²⁶University of Edinburgh, Edinburgh, United Kingdom, ²⁷Rheumatology, The Queen Elizabeth Hospital, South Australia, Adelaide, Australia, ²⁸Research Institute for Primary Care and Health Sciences, Keele University, Keele, United Kingdom, ²⁹Flinders Medical Centre and Repatriation Hospital, Adelaide, Australia, ³⁰Divisions of Rheumatology and Genetics, Brigham and Women's Hospital, Boston, MA, ³¹Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic, ³²P3 Research Limited, Wellington, New Zealand, ³³Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Germany, ³⁴La Paz University Hospital, Madrid, Spain, ³⁵Department of Medical Chemistry, Kurume University School of Medicine, Kurume, Japan, ³⁶Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ³⁷Discovery Biology, Ardea Biosciences, Inc., San Diego, CA, ³⁸Rheumatology, CHUV, Univ of Lausanne, Lausanne, Switzerland, ³⁹University of Otago, Christchurch, New Zealand, ⁴⁰Biochemistry, University of Otago, Dunedin, New Zealand
A genome-wide association study of gout in people of European ancestryBackground/Purpose: Genome wide association studies (GWAS) have provided considerable insight into the molecular control of…
Abstract Number: 1105 • 2017 ACR/ARHP Annual Meeting
Allopurinol Dose Escalation to Achieve Serum Urate below 6mg/Dl: An Open Label Extension Study
Lisa K. Stamp¹, Peter T. Chapman², Murray Barclay³, Anne Horne⁴, Christopher Frampton¹, Paul Tan⁵, Jill Drake⁶ and Nicola Dalbeth⁵, ¹University of Otago, Christchurch, New Zealand, ²Christchurch Hospital, Christchurch, New Zealand, ³Medicine, University of Otago, Christchurch, New Zealand, ⁴Department of Medicine, University of Auckland, Auckland, New Zealand, ⁵University of Auckland, Auckland, New Zealand, ⁶Rheumatology, Immunology and Allergy, Christchurch Hospital, Christchurch, New Zealand
Background/Purpose: Allopurinol at higher than CrCL based doses remains controversial due to concerns over increased risk of adverse events (AE). A recent 12month randomized controlled…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].